Active — Not RecruitingNot Applicable

Screening for NAFLD in Flanders

Belgium10,000 participantsStarted 2020-10-26

Plain-language summary

In the Belgian adult population more than half, and numbers are still increasing, of the population is overweight or obese. These people are at risk to develop NAFLD. However, we lack epidemiological data in Belgium. Therefore, it is important to do epidemiological studies to investigate NAFLD prevalence and disease severity based on a non-invasive approach and evaluate how patients are to be referred.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years or older, * able to understand Dutch, * able to understand the informed consent Exclusion Criteria: * secondary causes of steatosis * excessive alcohol abuse

What they're measuring

CLDQ-NAFLD

Timeframe: baseline

36-Item Short Form Survey (SF-36)

Timeframe: baseline

Trial details

NCT IDNCT04647409

SponsorHasselt University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-30

View on ClinicalTrials.gov More Non-Alcoholic Fatty Liver Disease trials